196 related articles for article (PubMed ID: 26355893)
21. PAX3-FOXO1 Establishes Myogenic Super Enhancers and Confers BET Bromodomain Vulnerability.
Gryder BE; Yohe ME; Chou HC; Zhang X; Marques J; Wachtel M; Schaefer B; Sen N; Song Y; Gualtieri A; Pomella S; Rota R; Cleveland A; Wen X; Sindiri S; Wei JS; Barr FG; Das S; Andresson T; Guha R; Lal-Nag M; Ferrer M; Shern JF; Zhao K; Thomas CJ; Khan J
Cancer Discov; 2017 Aug; 7(8):884-899. PubMed ID: 28446439
[TBL] [Abstract][Full Text] [Related]
22. PAX3-FOXO1 fusion gene in rhabdomyosarcoma.
Linardic CM
Cancer Lett; 2008 Oct; 270(1):10-8. PubMed ID: 18457914
[TBL] [Abstract][Full Text] [Related]
23. Biphenotypic sinonasal sarcoma: an expanded immunoprofile including consistent nuclear β-catenin positivity and absence of SOX10 expression.
Rooper LM; Huang SC; Antonescu CR; Westra WH; Bishop JA
Hum Pathol; 2016 Sep; 55():44-50. PubMed ID: 27137987
[TBL] [Abstract][Full Text] [Related]
24. The comparative utility of fluorescence in situ hybridization and reverse transcription-polymerase chain reaction in the diagnosis of alveolar rhabdomyosarcoma.
Thway K; Wang J; Wren D; Dainton M; Gonzalez D; Swansbury J; Fisher C
Virchows Arch; 2015 Aug; 467(2):217-24. PubMed ID: 25912319
[TBL] [Abstract][Full Text] [Related]
25. A Fusion Transcription Factor-Driven Cancer Progresses to a Fusion-Independent Relapse via Constitutive Activation of a Downstream Transcriptional Target.
Boudjadi S; Pandey PR; Chatterjee B; Nguyen TH; Sun W; Barr FG
Cancer Res; 2021 Jun; 81(11):2930-2942. PubMed ID: 33589519
[TBL] [Abstract][Full Text] [Related]
26. [Clinicopathological and molecular features of biphenotypic sinonasal sarcoma].
Wu N; Wang X; Cheng K; Wei X; Zhang RS; Lu ZF; Rao Q
Zhonghua Bing Li Xue Za Zhi; 2020 Dec; 49(12):1261-1266. PubMed ID: 33287510
[No Abstract] [Full Text] [Related]
27. Biphenotypic Sinonasal Sarcoma with a Novel PAX7::PPARGC1 Fusion: Expanding the Spectrum of Gene Fusions Beyond the PAX3 Gene.
Bhele S; Chrisinger JSA; Farrell NF; Van Tine BA; Raptis CA; Chernock RD
Head Neck Pathol; 2023 Sep; 17(3):826-831. PubMed ID: 37378830
[TBL] [Abstract][Full Text] [Related]
28. Biphenotypic Sinonasal Sarcoma: A Review and Update.
Carter CS; East EG; McHugh JB
Arch Pathol Lab Med; 2018 Oct; 142(10):1196-1201. PubMed ID: 30281368
[TBL] [Abstract][Full Text] [Related]
29. Novel PAX3::INO80D Fusion in Biphenotypic Sinonasal Sarcoma in an Adult.
Viramontes A; Mueller N; Gocke CD; Deklotz TR; Ozdemirli M
JAMA Otolaryngol Head Neck Surg; 2023 Sep; 149(9):849-850. PubMed ID: 37440250
[TBL] [Abstract][Full Text] [Related]
30. Sinonasal rhabdomyosarcoma in children and young adults.
Ahmed AA; Tsokos M
Int J Surg Pathol; 2007 Apr; 15(2):160-5. PubMed ID: 17478770
[TBL] [Abstract][Full Text] [Related]
31. Impact of fusion gene status versus histology on risk-stratification for rhabdomyosarcoma: Retrospective analyses of patients on UK trials.
Selfe J; Olmos D; Al-Saadi R; Thway K; Chisholm J; Kelsey A; Shipley J
Pediatr Blood Cancer; 2017 Jul; 64(7):. PubMed ID: 28035744
[TBL] [Abstract][Full Text] [Related]
32. PAX3-FOXO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis.
Marshall AD; Lagutina I; Grosveld GC
Cancer Res; 2011 Dec; 71(24):7471-80. PubMed ID: 22037868
[TBL] [Abstract][Full Text] [Related]
33. Biphenotypic sinonasal sarcoma-A recently described entity with many mimics: A case report.
Ingle A; Mahendra N; Gopal Reddy GV
Indian J Pathol Microbiol; 2023; 66(2):396-399. PubMed ID: 37077095
[TBL] [Abstract][Full Text] [Related]
34. Identification of serines 201 and 209 as sites of Pax3 phosphorylation and the altered phosphorylation status of Pax3-FOXO1 during early myogenic differentiation.
Dietz KN; Miller PJ; Iyengar AS; Loupe JM; Hollenbach AD
Int J Biochem Cell Biol; 2011 Jun; 43(6):936-45. PubMed ID: 21440083
[TBL] [Abstract][Full Text] [Related]
35. A novel PAX3 rearrangement in embryonal rhabdomyosarcoma.
Hosoi H; Kakazu N; Konishi E; Tsuchihashi Y; Hada S; Amaya E; Nakabayahi Y; Misawa-Furihata A; Tabata-Maruyama H; Iehara T; Sugimoto T; Yamane H; Yamasaki M; Shiwaku K; Yanagisawa A; Ono M; Tokiwa K; Iwai N; Hashiba M; Abe T; Sawada T
Cancer Genet Cytogenet; 2009 Mar; 189(2):98-104. PubMed ID: 19215790
[TBL] [Abstract][Full Text] [Related]
36. P/CAF mediates PAX3-FOXO1-dependent oncogenesis in alveolar rhabdomyosarcoma.
Bharathy N; Suriyamurthy S; Rao VK; Ow JR; Lim HJ; Chakraborty P; Vasudevan M; Dhamne CA; Chang KT; Min VL; Kundu TK; Taneja R
J Pathol; 2016 Nov; 240(3):269-281. PubMed ID: 27453350
[TBL] [Abstract][Full Text] [Related]
37. RREB1-MKL2 fusion in a spindle cell sinonasal sarcoma: biphenotypic sinonasal sarcoma or ectomesenchymal chondromyxoid tumor in an unusual site?
Mechtersheimer G; Andrulis M; Delank KW; Volckmar AL; Zhang L; von Winterfeld M; Stenzinger A; R Antonescu C
Genes Chromosomes Cancer; 2021 Aug; 60(8):565-570. PubMed ID: 33715240
[TBL] [Abstract][Full Text] [Related]
38. [Diagnostic challenge of biphenotypic sinonasal sarcoma].
Benzerdjeb N; Tantot J; Ameur F; Philouze P; Devouassoux-Shisheboran M
Ann Pathol; 2019 Aug; 39(4):297-300. PubMed ID: 30824316
[TBL] [Abstract][Full Text] [Related]
39. Regulation of target genes of PAX3-FOXO1 in alveolar rhabdomyosarcoma.
Ahn EH
Anticancer Res; 2013 May; 33(5):2029-35. PubMed ID: 23645752
[TBL] [Abstract][Full Text] [Related]
40. Fusion of the Paired Box 3 (
Panagopoulos I; Gorunova L; Andersen K; Lund-Iversen M; Tafjord S; Micci F; Heim S
Cancer Genomics Proteomics; 2021; 18(6):723-734. PubMed ID: 34697065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
